Differentiation of re
Vitamin is an international health care products has always been an important part of the market. For example, in the United States, the world’s largest health care products market, sales of vitamin products accounted for almost 1 / 4. With the continuous development of medical theory of health, scientists have come to realize that many kinds of vitamins with anti-aging, improve human body immunity, anti-tumor, anti-free radicals and certain other kinds of important role. Previously unknown folic acid is one example. Now know that folic acid has anti-teratogenic, promote infant brain cell development and the prevention of Alzheimer’s disease and other important physiological functions. The VE is newly found to have anticancer effects and the prevention of cataract formation. New uses for the above-mentioned vitamin international vitamin industry entered a new round of high-speed development period.
Large companies have moved factories vitamin industry, formerly the West of large companies “dominating the world.” Such as vitamin C, vitamin E, ?-carotene and other bulk vitamin products had previously been Roche, BASF, Takeda monopolized by large companies such as. To the 20th century, early 80s, China’s first vitamin-producing countries to enter the ranks and became the world’s largest VC production and exporting countries. Currently, China’s VC production enough to influence international VC market price. In this new situation, the international VC giant Roche began to seek cooperation with China and the transfer of part of VC production of raw materials to China. This is the vitamin produced by the first inter-continental cooperation. Western countries, the transfer of production of VE and VC is similar. 15 years ago, VE is almost 90% of total production concentrated in European countries. Forced labor costs remain high, Roche, BASF and other large companies began to VE production to relatively low labor costs in Asia and South America.
Early in the 20th century and the early 90s, with Shanghai Roche Pharmaceutical sixth co-production VE. Since then, BASF Zeyi 600 million U.S. dollars to buy Japan’s Takeda Chemicals, Inc. of vitamin E manufacturing facility. In June 2003, BASF has closed, is based in the United States, South Carolina, VE production base will be transferred to its relatively cheap labor costs in Mexico and Guatemala and other South American countries. To further reduce production costs, improve economic efficiency, BASF turn its located in Ontario, Canada, VE production base close to its German home city of VE Ludwig product line expanded to an annual output of 20000 tons; and Luo s also closed in the United States, New Jersey, VE production base and moved to the Swiss native, so that VE production base is located in Switzerland, the annual production capacity to 25000 ton, thus enhancing its VE products in international market competition.
Frequent cooperation with other Asian countries
Asia’s population accounts for 45% of the world’s population, and economic development in Asia over the past few years in good shape, so Asia is also an important market for one of the vitamin. It is learned that, following the Roche co-production with China after the VC, BASF has also set up a South Korean city of Busan, vitamin B2 fermentation plant, produce 2,000 tons of VB2. In Europe, BASF plans to build a 40000-ton citral plant. Citral is the production of vitamin A, vitamin E, p-carotene, an important intermediate. Netherlands-based DSM (DSM) has been replaced by Roche to become the world’s largest vitamin manufacturers.
It is reported that DSM last year, Roche bought 40% stake in vitamin production, which has a Roche in Europe, China, South America and other places part of the property. Roche last year, total sales of vitamin products reached 23 billion euros. In addition, DSM has purchased 21% of the shares of BASF, and several of the company’s vitamin production lines to their own name, then, DSM has acquired the company’s livestock Ruishi An Aventis vitamin production company, so far, DSM has justifiably become the world’s largest vitamin companies, and long-term ranking first in the global vitamin industry, Roche is sadly relegated to second place.
Roche’s new initiatives
Roche is one of the strategic new initiatives important to look after the house of its products – feed additives use “pre-mixed vitamin” production bases to Asia and Latin America to meet the rapid development in Asia and Latin America, breeding industry needs. It is reported that last year, Roche in Pusan City and Sao Paulo, South America, respectively, the two opened a livestock vitamin premix plant, annual production capacity of 4000 tonnes, respectively, 8,000 tons, in the future will depend on the situation to expand annual production capacity. In addition, Roche is also planning in Europe, South America, Chile, Hungary and the construction of animals were vitamin premix plants to adapt to the local farming industry. BASF to be in 2005 in France and Malaysia to build a 5,000-ton annual output of feed vitamin premix plant.
Near According to foreign reports, Roche will also be built in Japan and Germany, VB2, VB6 fermentation production base, so that total vitamin B-Roche remains on the world. It is understood that, VB2 and VB6 has become a best-selling products on the international market, its annual sales volume has reached 2 million tons, the next five years, including VB2, VB6, including B vitamins are expected to increase to 4 million tons or more.
To sum up, the international vitamin industry is facing an unprecedented large division, major reorganization, a great shift in a new situation, after 20 years of rapid development; the vitamin industry in China has been recognized by the international community, several kinds of vitamin products (such as VC, Biotin, VK, etc.) has been in the world pharmaceutical market dominant. China’s pharmaceutical enterprises should seize the restructuring of the international division of vitamin industry, an excellent opportunity to bring into full play the advantages of cheap domestic labor costs, and strive to niacin / niacinamide weak links such as a breakthrough, and truly become Asia and the world of vitamin producer.
I am China Manufacturers writer, reports some information about zinc sulphate heptahydrate , sodium sulfate anhydrous.
Processing your request, Please wait....
